MIA joins Sydney Health Partners

MIA joins Sydney Health Partners

22 December 2021

Melanoma Institute Australia (MIA) has joined Sydney Health Partners, becoming the 16th health organisation and 11th Medical Research Institute in the growing Partnership.

MIA is a nationally-affiliated network of melanoma researchers and clinicians based in Sydney at The Poche Centre– the world’s largest melanoma research and treatment facility.

The membership builds on MIA’s existing affiliations with four founding members of Sydney Health Partners - the University of Sydney, and Sydney, Northern Sydney and Western Sydney Local Health Districts.

Sydney Health Partners’ Executive Director, Professor Don Nutbeam, has welcomed MIA, saying “culturally there’s a great fit between Melanoma Institute Australia and what we are aspiring to achieve across the health system with our health partners.”  

“Like MIA, we seek a faster, better fit between the world class research that’s going on across all our Partners, the quality care we are looking to deliver to our patients and the public benefit that we are trying to deliver to wider society.”

 

Co-Medical Director of MIA, Professor Georgina Long AO, says Melanoma Institute Australia shares Sydney Health Partners’ focus on more rapidly translating research evidence into patient benefit.

“You can have great ideas, but you’ve got to test the ideas and ultimately, if the idea is worthwhile and impacts outcomes for patients then you’ve got to make sure that gets introduced to the rest of Australia and the rest of the world.”

According to MIA Co-Medical Director, Professor Richard Scolyer AO, it’s vital that MIA does more than just find answers to the clinical questions that arise when treating patients.

“We are the largest melanoma treatment centre in the world and because of that we see patterns and there are questions that come up that need to be addressed,” he said. “So, when we find answers to those questions, we are committed to implementing changes to get better outcomes for our patients.”

Professor Nutbeam says that while MIA will hopefully benefit from collaborating with a wider community of research translators, the Institute has just as much to offer the Partnership.

“I think that because of their track record and experience they have a fair bit to teach us about how to get this right and get the closest possible connection between outstanding research and great clinical care.”

Sydney Health Partners is accredited by the National Health and Medical Research Council as an Advanced Health Research and Translation Centre.

Commencing operations in 2016 with 14 members, the Partnership subsequently welcomed the Kolling Institute of Medical Research in 2019.

With the addition of Melanoma Institute Australia, Sydney Health Partners is now one of the largest academic health science centres in the world.

Collectively, the Partners provide care to 2.7 million people, representing more than 10 per cent of the Australian population.

Sydney Health Partners’ goal is to demonstrate that new evidence-based interventions can be successfully implemented and scaled-up in large and diverse health systems.

“Since Sydney Health Partners’ establishment, the health system’s need for better research translation has only become more obvious,” said Professor Nutbeam.

“So, we were really delighted when the MIA contacted us to become partners with Sydney Health Partners.

“They exemplify a lot of the things we are trying to get right in our health care system – outstanding world class research being connected to patient care as quickly and efficiently as possible.”

Professors Long and Scolyer describe joining Sydney Health Partners as “a fantastic opportunity to work with people with the breadth of experience, knowledge and skills to have those research findings implemented.”

“To make things happen you need policy, you need energy and you need advocacy – and that can only be done when you bring the right groups of people, with different skills sets, together.”

Read more about Sydney Health Partners here

New research to guide clinicians to more accurately stage and manage melanoma patients
16 Nov 2017

New research to guide clinicians to more accurately stage and manage melanoma patients

New research from MIA has been published that forms the basis of the updated international guidelines for staging melanoma.

Founding father recognised for outstanding cancer care
15 Nov 2017

Founding father recognised for outstanding cancer care

Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.

Melanoma researchers shine at the State's premier cancer awards ceremony
03 Nov 2017

Melanoma researchers shine at the State's premier cancer awards ceremony

Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.

Enhancing melanoma treatment response through gut bacteria
03 Nov 2017

Enhancing melanoma treatment response through gut bacteria

New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.

Melanoma March is just around the corner!
01 Nov 2017

Melanoma March is just around the corner!

2018 will be bigger than ever, and a little bit different.

Comparing melanoma risk in similar populations across different latitudes
20 Oct 2017

Comparing melanoma risk in similar populations across different latitudes

MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.

Congratulations to our Conjoint Medical Directors
19 Oct 2017

Congratulations to our Conjoint Medical Directors

Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.

What causes melanoma in 90% of young Australians?
19 Oct 2017

What causes melanoma in 90% of young Australians?

New research shows potentially deadly UV damage can appear decades earlier than you think.

Early lymph node check is saving lives in melanoma patients
19 Oct 2017

Early lymph node check is saving lives in melanoma patients

Early lymph node check is saving lives in melanoma patients

Congratulations to Associate Professor Anne Cust
13 Oct 2017

Congratulations to Associate Professor Anne Cust

We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.

Smoking linked to increased risk of melanoma spreading
12 Oct 2017

Smoking linked to increased risk of melanoma spreading

New research has shown that melanoma patients who smoke have an increased risk of their disease progressing compared to patients who do not smoke.

Research boost to improve outcomes for patients
11 Oct 2017

Research boost to improve outcomes for patients

More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.

Highlights in melanoma research from ESMO
21 Sep 2017

Highlights in melanoma research from ESMO

The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.

Australian researchers stopping melanoma in its tracks
11 Sep 2017

Australian researchers stopping melanoma in its tracks

Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.

Virus-antibody combo shows promise for treating advanced melanoma
08 Sep 2017

Virus-antibody combo shows promise for treating advanced melanoma

A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.

It's time to outlaw sunburn on reality TV shows - enough is enough
31 Jul 2017

It's time to outlaw sunburn on reality TV shows - enough is enough

It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.

Identifying markers for optimal response
28 Jul 2017

Identifying markers for optimal response

Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?

Global Melanoma Research Report - July
20 Jul 2017

Global Melanoma Research Report - July

In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.

A day in the life of... Sarah Lane
14 Jul 2017

A day in the life of... Sarah Lane

Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process. 

Differentiating moles from melanoma
14 Jul 2017

Differentiating moles from melanoma

Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.